Abstract:Abstract Background The aim of the study was to assess the perception of inflammatory bowel disease (IBD) among Chinese patients and physicians. Methods Data in this cross-sectional study was collected from 6/2020 to 8/2020, which covered 24 provinces/cities in China and based on two surveys that was designed for collecting information from patients with Crohn’s disease (CD)/ulcerative colitis (UC) and the physicians. Results Surveys were completed by 1058 patients (601 CD and 457 UC patients) and 351 physicians (181 treating CD and 170 treating UC). For the control of disease symptoms over the past 12 months, physicians believed that 65.19% and 57.65% of CD and UC patients, respectively, were managed without affecting their quality of life. Meanwhile, 56.07% and 49.46% of CD and UC patients, respectively, reported that disease control did not affect their quality of life. Physicians estimated that 87.85% of CD and 88.24% of UC patients were satisfied with treatment results. And 86.36% of CD and 79.43% of UC patients were satisfied with the current medications. Physicians prescribed biologics for 69.52% of IBD patients, and 48.3% of IBD patients actually used them. Repeated medication (30.95%), diarrhea (27.95%) and abdominal pain (25.29%) were most frequently ranked as most bothersome symptoms by CD patients. For physicians, abdominal pain (42.54%) was the most bothersome symptoms, followed by repeated medication (23.76%) and diarrhea (17.13%). Regarding UC symptoms, 51.18% of physicians believed that bloody stool was the most bothersome symptom for patients, and 41.58% of patients held this view. The sense of urgency was concerned as one bothersome symptom by 19.69% patients, while only 4.12% of physicians held the same views (Fig 1). Regarding the efficacy evaluation, in view of the CD physicians, 42.5% of CD patients were believed achieving completely or mostly controlled, while from the patients’ perception, only 32.6% of CD patients agreed. Similarly, the proportion of UC patients who was believed by physicians that achieving completely or mostly controlled (40.0%) was also higher than that of UC patients who believed by themselves (Fig 2). Conclusion Most of the IBD patients and physicians were satisfied with the treatment results and the current medications. The disease control expectation of the patients was slightly more than that of the physicians. Further studies are needed to explore factors that associated with the treatment expectation of the patients.

Clinical features of Crohn′s disease and therapy:a comparison between 85 Chinese patients and 68 American patients

The Differences Between American and Chinese Patients with Crohn’s Disease

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Clinical Presentation of Inflammatory Bowel Disease： a Hospital Based Retrospective Study of 379 Patients in Eastern China

Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients

P479 Trends in Medication Use and Treatment Patterns in Chinese Patients with Inflammatory Bowel Diseases: A Multicenter Cohort Study from 1999 to 2020

Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China

The clinical characteristics and treatment evaluation of patients with Crohn's disease

Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China

Quality of Care for Patients with Inflammatory Bowel Disease in East China

P1109 Differences of Clinical Phenotype Between Familial and Sporadic Crohn's Disease in East China

Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States

An analysis of histopathological features of Crohn’s disease in surgical specimens

Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease

P467 Perception Gap Between Patients with Inflammatory Bowel Disease (IBD) and Physicians in China: A Cross-sectional Study

Clinical Characteristics of Non-Perianal Fistulating Crohn'S Disease in China: A Single-Center Experience of 184 Cases

P282 Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Prognosis of Crohn’s Disease in Chinese Population

Temporal trends in surgery for Crohn’s disease: A ten-year single-center retrospective study

The Analysis of Clinical Characteristics and Treatment of 234 Patients with Intractable Ulcerative Colitis

Comparison of Clinical Characteristics and Management of Inflammatory Bowel Disease in Hong Kong Versus Melbourne

Clinical Characteristics of 379 Patients with Inflammatory Bowel Disease